SquidPERI for prostate artery embolization
Part of Kidney & urinary clinical trials.
This trial tests a new material called SquidPERI for prostate artery embolization (PAE), a procedure to reduce prostate size and improve urine flow. It aims to see if SquidPERI works well and safely for patients who already need this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor has already scheduled you for a prostate artery embolization using SquidPERI
- You understand and have signed a consent form
- You have French health insurance (social security)
- You can understand and speak French well
- You do not have a severe allergy to iodine
- You do not have severe liver problems
- You have not had a prostate artery embolization before
- You are not taking part in another clinical trial right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a procedure called prostate artery embolization (PAE) can help shrink the prostate before radiation therapy. It may improve urinary symptoms for men with an enlarged prostate and high symptom scores.
This Phase 3 study tests whether treating the arteries feeding the prostate can reduce urinary symptoms from benign prostatic hyperplasia (BPH). It may help men whose BPH symptoms persist despite (or can’t be treated with) usual medications.
This trial compares artery embolization (blocking blood flow to the prostate) with standard surgery for urinary symptoms caused by an enlarged prostate. It may help patients who have moderate-to-severe bladder outlet symptoms and are looking for a treatment option when medicine didn’t work (or they don’t want medicine).
This trial compares using medical glue versus tiny beads to block blood flow to the prostate, which can shrink it and improve urine flow. It is for men whose enlarged prostate symptoms have not improved with medication.
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
This study tests a new device (Vivifi) that aims to treat an enlarged prostate without surgery. The goal is to improve urine flow and reduce symptoms like frequent or weak urination.
Hear when a new Benign Prostate Hypertrophy(BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.